Win-Partners Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year Ending March 31, 2025
May 14, 2024 at 07:00 am
Share
WIN-Partners Co., Ltd. provided consolidated earnings guidance for the first half and full year ending March 31, 2025. For the first half, the company expects net sales of ¥37,300 million, an Operating profit of ¥1,070 million, profit attributable to owners of the parent of ¥725 million or ¥25.38 basic per share.
For the full year, the company expects net sales of ¥78,000 million, an Operating profit of ¥2,750 million, Profit attributable to owners of the parent of ¥1,860 million or ¥65.12 basic per share.
WIN-Partners Co., Ltd. is a Japan-based company primarily engaged in the medical equipment supply business through its subsidiaries. The Company is mainly in the provision of medical device, such as catheters used in ischemic heart disease, pacemakers used in cardiac rhythm management area, artificial blood vessels used for cardiovascular surgery area, embolization coil used in peripheral vascular disease and brain surgery, as well as the provision of large -scale medical equipment, such as computed tomography equipment (CT) used in the radiology department and the operating room.
WIN-PARTNERS CO., LTD. 
